THE CLIENT ASK:
Draw attention to a new understanding of the roots and treatment of dyspareunia: painful intercourse associated with menopausal VVA.
Despite the impact on women’s lives, this condition has been under-treated by HCPs due to patient concerns about the safety of estrogen, the primary therapeutic option.
Our mission: introduce new learnings (and condition the market for a new therapy) for the role DHEA plays in the condition and treatment.
Created a provocative, interactive conference experience, designed to engage HCPs and enroll them in ongoing CRM.
Developed a companion website that focused on the physiology of the condition; the sex hormone (DHEA) mechanism by which it is manifested and the science behind reversing the condition.